NO913292L - Fremgangsmaate og anvendelse av 6,7-dihydro-3-fenyl-1,2-benzisoksazol-4(5h)-oner og -oler. - Google Patents

Fremgangsmaate og anvendelse av 6,7-dihydro-3-fenyl-1,2-benzisoksazol-4(5h)-oner og -oler.

Info

Publication number
NO913292L
NO913292L NO91913292A NO913292A NO913292L NO 913292 L NO913292 L NO 913292L NO 91913292 A NO91913292 A NO 91913292A NO 913292 A NO913292 A NO 913292A NO 913292 L NO913292 L NO 913292L
Authority
NO
Norway
Prior art keywords
chem
formula
loweralkyl
hydrogen
arylloweralkyl
Prior art date
Application number
NO91913292A
Other languages
English (en)
Norwegian (no)
Other versions
NO913292D0 (no
Inventor
David Gordon Wettlaufer
Gregory Michael Shutske
Peter Allen Nemoto
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of NO913292D0 publication Critical patent/NO913292D0/no
Publication of NO913292L publication Critical patent/NO913292L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO91913292A 1990-08-23 1991-08-22 Fremgangsmaate og anvendelse av 6,7-dihydro-3-fenyl-1,2-benzisoksazol-4(5h)-oner og -oler. NO913292L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57148290A 1990-08-23 1990-08-23
US07/692,341 US5114936A (en) 1990-08-23 1991-04-26 6,7-dihydro-3-phenyl-1,2-benzisoxazol-4(5h)-ones and -ols, compositions and pharmaceutical use

Publications (2)

Publication Number Publication Date
NO913292D0 NO913292D0 (no) 1991-08-22
NO913292L true NO913292L (no) 1992-02-24

Family

ID=27075593

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91913292A NO913292L (no) 1990-08-23 1991-08-22 Fremgangsmaate og anvendelse av 6,7-dihydro-3-fenyl-1,2-benzisoksazol-4(5h)-oner og -oler.

Country Status (20)

Country Link
US (1) US5114936A (fr)
EP (1) EP0474012B1 (fr)
JP (1) JP3018619B2 (fr)
KR (1) KR0173685B1 (fr)
AT (1) ATE145644T1 (fr)
AU (1) AU634944B2 (fr)
CA (1) CA2049733C (fr)
CS (1) CS260191A3 (fr)
DE (1) DE69123315T2 (fr)
DK (1) DK0474012T3 (fr)
ES (1) ES2095277T3 (fr)
FI (1) FI913957L (fr)
GR (1) GR3022697T3 (fr)
HU (1) HU215439B (fr)
IE (1) IE76138B1 (fr)
IL (1) IL99264A (fr)
NO (1) NO913292L (fr)
NZ (1) NZ239494A (fr)
PT (1) PT98747B (fr)
YU (1) YU142991A (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114960A (en) * 1989-07-20 1992-05-19 Hoffmann-La Roche Inc. Substituted isoxazole derivatives
US5225412A (en) * 1991-04-29 1993-07-06 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
GB2264299B (en) * 1992-02-19 1995-07-26 British Tech Group Iso-oxazolidine derivatives
GB9226857D0 (en) * 1992-12-23 1993-02-17 Boyd Edward A Pharmaceutical compositions
GB2284600A (en) * 1994-01-21 1995-06-14 Shell Int Research Herbicidal 3-(hetero)aryl-4-acylisoxazole compositions and compounds
ATE247110T1 (de) * 1999-09-14 2003-08-15 Aventis Pharma Inc Benzisoxazolyl-, pyridoisoxazolyl- und benzthienyl-phenoxy derivate als d4 antagonisten
US7253165B2 (en) * 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
JP4544864B2 (ja) 2002-03-08 2010-09-15 独立行政法人科学技術振興機構 イソキサゾール誘導体及びその製造方法
US6770659B2 (en) 2002-08-26 2004-08-03 Sk Corporation Benzoyl piperidine compounds
JP4909344B2 (ja) 2006-03-22 2012-04-04 株式会社冨永樹脂工業所 水槽用オーバーフロー装置
EP2055186B1 (fr) 2006-08-25 2011-10-26 Kabushiki Kaisha Tominaga Jyushi Kogyosho Dispositif de trop-plein pour un réservoir d'eau
EP3290403A3 (fr) * 2012-09-14 2018-03-21 Supernus Pharmaceuticals, Inc. Procédés de production de molindone et de ses sels
JP7387605B2 (ja) 2018-07-23 2023-11-28 住友ファーマ株式会社 縮環ラクタム誘導体
US10745401B2 (en) 2018-07-23 2020-08-18 Sumitomo Dainippon Pharma Co., Ltd. Condensed lactam derivative
EP4429465A1 (fr) 2021-11-10 2024-09-18 Symrise AG Compositions comprenant des agents de refroidissement agonistes de trpm8

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4010176A (en) * 1972-10-27 1977-03-01 Merck & Co., Inc. Isoxazole substituted nitroimidazoles
US4217349A (en) * 1974-07-01 1980-08-12 Sumitomo Chemical Company, Limited Benzisoxazole derivatives
US4156005A (en) * 1978-06-21 1979-05-22 Merck & Co., Inc. Derivatives of 1,2-benzisoxazoles
GB2024008B (en) * 1978-06-28 1983-02-16 Merck & Co Inc Compositions for treating trypanosomiasis infections
EP0063799B1 (fr) * 1981-04-27 1985-11-27 Hoechst-Roussel Pharmaceuticals Incorporated ((Fluoro-6-benzisoxazol 1,2-yl-3)propyl-3)-1-hydroxy-4-phénylpipéridines-4, leur préparation et leur emploi comme médicaments
IL66866A (en) * 1982-04-09 1987-08-31 Hoechst Roussel Pharma 1-(3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl)-4-(substituted)-piperazines and-piperidines,a process for the preparation thereof,and pharmaceutical compositions containing them
US4458075A (en) * 1982-04-09 1984-07-03 Hoechst-Roussel Pharmaceuticals Inc. 6-Fluoro-3-[3-(1-heterocyclo)propyl]-1,2-benzisoxazoles
ATE81975T1 (de) * 1984-12-21 1992-11-15 Duphar Int Res Arzneimittel mit psychotroper wirkung.
US4994455A (en) * 1987-10-26 1991-02-19 Pfizer Inc. Anti-anxiety agents
US5114960A (en) * 1989-07-20 1992-05-19 Hoffmann-La Roche Inc. Substituted isoxazole derivatives

Also Published As

Publication number Publication date
NO913292D0 (no) 1991-08-22
PT98747B (pt) 1999-01-29
DE69123315D1 (de) 1997-01-09
NZ239494A (en) 1994-08-26
FI913957A7 (fi) 1992-02-24
GR3022697T3 (en) 1997-05-31
IE912976A1 (en) 1992-02-26
DK0474012T3 (da) 1997-05-12
AU8261791A (en) 1991-11-07
AU634944B2 (en) 1993-03-04
JP3018619B2 (ja) 2000-03-13
IL99264A0 (en) 1992-07-15
PT98747A (pt) 1992-07-31
HU215439B (hu) 1999-09-28
CS260191A3 (en) 1992-04-15
YU142991A (sh) 1995-01-31
KR920004366A (ko) 1992-03-27
HUT61533A (en) 1993-01-28
US5114936A (en) 1992-05-19
EP0474012A1 (fr) 1992-03-11
CA2049733C (fr) 2003-10-21
KR0173685B1 (ko) 1999-02-01
ES2095277T3 (es) 1997-02-16
FI913957A0 (fi) 1991-08-21
IL99264A (en) 1996-01-19
EP0474012B1 (fr) 1996-11-27
JPH04230673A (ja) 1992-08-19
CA2049733A1 (fr) 1992-02-24
ATE145644T1 (de) 1996-12-15
DE69123315T2 (de) 1997-05-22
FI913957L (fi) 1992-02-24
IE76138B1 (en) 1997-10-08
HU912756D0 (en) 1992-01-28

Similar Documents

Publication Publication Date Title
NO913292D0 (no) Fremgangsmaate og anvendelse av 6,7-dihydro-3-fenyl-1,2-benzisoksazol-4(5h)-oner og -oler.
FI904327A0 (fi) N-substituerad-4-pyrimidinaminer och -pyrimidindiaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
DK645688A (da) 3-(4-(1-substitueret 4-piperazinyl)butyl)-4-thiazolidinoner, deres fremstilling og anvendelse
DE69522703D1 (de) Aminotetrazol-derivate verwendbar als stickstoff-oxid-synthase inhibitoren
ATE180780T1 (de) 2-(piperidin-4-yl, pyridin-4-yl und tetrahydropyridin-4-yl)-benzofuran-7-carbamat derivate, ihre herstellung und verwendung als acetylcholinesterase inhibitoren
DE69224212D1 (de) Piperazinderivate als 5-ht1a antagonisten.
MY111486A (en) 1,2,4-triazine derivatives, production and use thereof.
AU646611B2 (en) 4-{4- or 6-(trifluoromethyl-2-pyridinyl)}-1-piperazinyl- alkyl substituted lactams
HU910584D0 (en) Process for producing 2,4,8-trisubstituted-3h,6h-1,4,5a,8a-tetraazacenaphthylene-3,5-(4h)-diones and 2,4,8-trisubstituted-4,5-dihydro-5-thioxo-3h,6h-1,4,5a,8a-tetraazacenaphthylene-3-ones
ATE130002T1 (de) 1-(pyridinylalkyl)-1h-indole, -indoline und analoge.
TR199600181A2 (tr) 4-alkiltio-pirimidin-5-ilasetik asit türevleri.
DK0458331T3 (da) Pyrido/3,4-b/ pyrrolo/ 1,2-e/ /1,4,5/oxadiazepiner og beslægtede analoge, fremgangsmåder til deres fremstilling og deres an
NO20052854L (no) Substituerte alkylpyridazinoner for behandlingen av hukommelses- og laeresvikt.
MY111604A (en) Piperidinyl compounds
DK0471298T3 (da) Carbamoyl-1-(pyridinylalkyl)-1H-indoler, -indoliner og belægtede forbindelser